HCPLive Network

High In-Utero Pollen Exposure Linked to Asthma in First Year

 
TUESDAY, Jan. 15 (HealthDay News) -- High pollen exposure in utero late in pregnancy is associated with an increased risk of asthma hospitalization during the first year of life, according to a study published online Nov. 7 in Allergy, Asthma & Clinical Immunology.

Adrian J. Lowe, Ph.D., M.P.H., from Umeå University in Sweden, and colleagues assessed the effect of pollen exposure in the first and last 12 weeks of pregnancy and the first 12 weeks of infancy for all children conceived by women residing in Stockholm between 1988 and 1995. Hospital admission data were used to assess respiratory conditions in the first year of life.

The researchers found that, by age 12 months, 940 of 110,381 children had been hospitalized for asthma. There were marked seasonal variations and between-year differences in pollen levels. There was an increased risk of asthma hospitalization for those exposed to high levels of pollen in the last 12 weeks of pregnancy (adjusted odds ratio [aOR], 1.35 for highest quartile versus remaining infants). Among children of mothers who smoked heavily, exposure to high levels of pollen in the first three months of life was associated with a significantly reduced risk of asthma hospitalization (aOR, 0.76).

"Replication of these findings is needed, as the results are somewhat surprising," the authors write. "If replicated, these findings may lead to mechanistic studies that help elucidate the pathogenesis of late pregnancy pollen exposure on respiratory outcomes, which could have therapeutic implications."
 

Abstract
Full Text

Copyright © 2013 HealthDay. All rights reserved.
 
 

Further Reading
Asthma prolongs time to pregnancy, according to a study published online Nov. 14 in the European Respiratory Journal
In the fifth to sixth decades of life, women have a significantly higher hospitalization rates for asthma compared to men, according to research published in the September issue of the Annals of Allergy, Asthma & Immunology.
With reimbursement increasingly tied to quality measures and other metrics, the question of whether best practices actually produce improved outcomes has taken on greater importance for clinicians and their patients.
An intravaginal ring containing drugs to prevent HIV transmission as well as pregnancy is able to deliver the drugs at effective levels for 90 days, according to a study presented at the annual meeting of the American Association of Pharmaceutical Scientists, held from Nov. 10 to 14 in San Antonio.
During his presentation, Dr. Carlos Camargo reviewed recent studies on the effects of menarche, menopause, and pregnancy on asthma, and described the implications for patients with asthma.
The American College of Rheumatology recently announced a new easy-to-use curriculum and tools aimed to help medical professionals advance the diagnosis, treatment, and management of lupus.
Dr. Lim discusses the challenges of diagnosing and treating lupus, the tools and resources offered by the Lupus Initiative, and the impact of unconscious bias on care.
More Reading